![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Center for Human Reproduction Foundation for Reproductive Medicine |
---|---|
Information provided by: | Center for Human Reproduction |
ClinicalTrials.gov Identifier: | NCT00419913 |
Our long term goal is to elucidate the role of DHEA on follicular dynamics in the human ovary and to better understand the interaction of DHEA supplementation with other treatments for ovulation induction, especially among older reproductive age women.
The specific hypothesis behind the proposed research is that DHEA is a regulator of follicular dynamics acting in the early pre-gonadotropin dependent stage of initial primordial follicle recruitment and growth.
Condition | Intervention | Phase |
---|---|---|
Infertility Decreased Ovarian Reserve |
Dietary Supplement: Dehydroepiandrosterone |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) Treatment for Two Months Before Starting Ovulation Induction for in Vitro Fertilization (IVF) |
Enrollment: | 8 |
Study Start Date: | January 2007 |
Study Completion Date: | January 2008 |
Primary Completion Date: | July 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental
Dehydroepiandrosterone (DHEA) 25mg tid
|
Dietary Supplement: Dehydroepiandrosterone
DHEA 25 mg tid
|
B: Placebo Comparator |
Dietary Supplement: Dehydroepiandrosterone
DHEA 25 mg tid
|
Ages Eligible for Study: | 40 Years to 45 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, New York | |
Center for Human Reproduction | |
New York, New York, United States, 10021 | |
Austria | |
Institute fur Reproduktionsmedzin und Endokrinologie | |
Bregenz, Austria |
Principal Investigator: | David Barad, MD | Center for Human Reproduction |
Responsible Party: | Center for Human Reproduction ( Dr. David H. Barad ) |
Study ID Numbers: | CHR2006 1.0 |
Study First Received: | January 7, 2007 |
Last Updated: | March 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00419913 |
Health Authority: | United States: Institutional Review Board |
Ovulation Induction In vitro Fertilization Pregnancy |
Genital Diseases, Female Infertility Dehydroepiandrosterone Genital Diseases, Male |
Immunologic Factors Physiological Effects of Drugs Adjuvants, Immunologic Pharmacologic Actions |